TrialScientific reports2017

Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status.

Hong Jian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.